Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparing Efficacy and Safety of Tacrolimus With Steroids or Monoclonal Anti-IL2R Antibody in HCV Positive in Liver Transplantation

NCT00295607 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT00295607
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00295607 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparing Efficacy and Safety of Tacrolimus With Steroids or Monoclonal Anti-IL2R Antibody in HCV Positive in Liver Transplantation
Lead sponsor
Astellas Pharma Inc
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2005
Completion date
June 30, 2008
Enrollment
138 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c, liver transplantation